DE35259T1 - Tetrahydrothiopyrano (3,2-b) indole derivatives, processes for their preparation and pharmaceutical compositions containing these compounds - Google Patents

Tetrahydrothiopyrano (3,2-b) indole derivatives, processes for their preparation and pharmaceutical compositions containing these compounds

Info

Publication number
DE35259T1
DE35259T1 DE1981101451 DE81101451T DE35259T1 DE 35259 T1 DE35259 T1 DE 35259T1 DE 1981101451 DE1981101451 DE 1981101451 DE 81101451 T DE81101451 T DE 81101451T DE 35259 T1 DE35259 T1 DE 35259T1
Authority
DE
Germany
Prior art keywords
compound according
compound
methyl
radical
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1981101451
Other languages
German (de)
Inventor
Yasuo Kawanishi Hyogo; Sasatani Takashi Kashihara Nara; JP Makisumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of DE35259T1 publication Critical patent/DE35259T1/en
Pending legal-status Critical Current

Links

Claims (7)

PatentansprücheClaims 1
in der R ein Wasserstoffatom, einen C.,-Alkyl-, C?_,-Alkenyl-, C~_,-Alkinyl-, C7-1„-Aralkyl- oder C„_. -Acylrest bedeutet, oder den Rest
1
in which R is a hydrogen atom, a C., - alkyl, C ? _, - alkenyl, C ~ _, - alkynyl, C 7-1 "-aralkyl- or C" _. -Acyl radical, or the remainder
5 -Y-N5 -Y-N darstellt, in dem Y einen C1_.-Alkylen- oder C1-.-Oxoalkylenrest und R und R je ein Wasserstoffatomrepresents in which Y is a C 1 alkylene or C _.- 1-.-Oxoalkylenrest and R and R are each a hydrogen atom oder einen C1_,-Alkylrest bedeuten;or a C 1 _, - mean alkyl; R ein Wasserstoffatom oder einen C1 ,-Alkylrest bedeutet; R represents a hydrogen atom or a C 1 , -alkyl radical; R ein Wasserstoff atom oder einen C1 _f--Alkylrest bedeutet oder den RestR is a hydrogen atom or a C 1 _ f -alkyl radical or the radical -Y-N-Y-N darstellt, in dem Y, R und R die vorstehend angegebene Bedeutung haben;
oder
represents, in which Y, R and R have the meanings given above;
or
,R, R -N'-N ' eine Pyrrolidino, Piperidinyl- oder Piperazinylgruppe, , ;, einen 4-e -Alkylpiperazinylrest oder eine Morpholinogruppe ;■;.. bedeutet;a pyrrolidino, piperidinyl or piperazinyl group, ,;, a 4-e-alkylpiperazinyl radical or a morpholino group ; ■; .. means; R ein Wasserstoffatom oder einen C. ,-Alkylrest bedeuten undR denotes a hydrogen atom or a C., alkyl radical and η den Wert O, 1 oder 2 hatη has the value 0, 1 or 2 und ihre pharmazeutisch verträglichen Salze.and their pharmaceutically acceptable salts.
2. Verbindung nach Anspruch 1, in der der C7-12-Aralkylrest ein Phenyl-C,._,-alkylrest ist.2. A compound according to claim 1, in which the C 7-12 aralkyl radical is a phenyl-C, ._, - alkyl radical. 3. Verbindung nach Anspruch 1, in der der C,., .-Acylrest einen Rest R CO darstellt, in dem R einen C, ^-Alkylrest, eine Phenylgruppe oder eine substituierte Phenylgruppe bedeutet.3. A compound according to claim 1, in which the C,.,. -Acyl radical represents a radical R CO, in which R is a C, ^ -alkyl radical, represents a phenyl group or a substituted phenyl group. 4. Verbindung nach Anspruch 1, in der R ein Wasserstoffatom bedeutet.4. A compound according to claim 1, in which R is hydrogen means. 4 5. Verbindung nach Anspruch 1, in der R eine Methylgruppe bedeutet.4 5. A compound according to claim 1, in which R is a methyl group. 6. Verbindung nach Anspruch 1, in der η den Wert 0 hat. 6. A compound according to claim 1, in which η is zero. 7. Verbindung nach Anspruch 1, in der η den Wert 1 hat.7. A compound according to claim 1, in which η is 1. 8. Verbindung nach Anspruch 4, in der R ein Wasserstoffatom oder einen C._fi-Alkylrest bedeutet.8. A compound according to claim 4, in which R is a hydrogen atom or a C._ fi -alkyl radical. 9. Verbindung nach Anspruch 8, in der R eine Methylgruppe bedeutet.9. A compound according to claim 8, in which R represents a methyl group. 10. Verbindung nach Anspruch 8, in der R ein Wasserstoffatom und R einen C, ,,-Alkylrest bedeutet.10. A compound according to claim 8, in which R is a hydrogen atom and R is a C 1, - alkyl radical. I —DI -D 3 " 003575-9 3 "003575-9 22 ■11. Verbindung nach Anspruch 8, in der R einen Cj_g-Alkyl-■ 11. A compound according to claim 8, in which R is a Cj_g alkyl rest und R. einen N,N-Di-C -alkylaminoäthylrest bedeu- Jrest and R. a N, N-Di-C -alkylaminoäthylrest meaning J I *— υI * - υ ten. :ten .: 12. Verbindung nach Anspruch 8, in der R und R je einen C1 ,-Alkylrest bedeuten.12. A compound according to claim 8, in which R and R each represent a C 1 -alkyl radical. I — DI - D 13. Verbindung nach Anspruch 10, in der R eine Methylgruppe13. A compound according to claim 10, in which R is methyl bedeutet.
10
means.
10
14. Verbindung nach Anspruch 11, in der R eine Methylgruppe14. A compound according to claim 11, in which R is methyl und R eine Ν,Ν-Diäthylaminoäthylgruppe bedeuten.and R is a Ν, Ν-diethylaminoethyl group. 2 32 3 15. Verbindung nach Anspruch 12, in der R und R je eine15. A compound according to claim 12, in which R and R are each one Methylgruppe bedeuten.Mean methyl group. 16. Verbindung nach Anspruch 1, nämlich 4-Methylaminomethyl-5-methyl-2,3,4,5-tetrahydrothiopyrano [3 ,2-b]indol.16. The compound of claim 1 which is 4-methylaminomethyl-5-methyl-2,3,4,5-tetrahydrothiopyrano [3 , 2-b] indole. '' 17. Verbindung nach Anspruch 1, nämlich 4-Methylaminomethyl-17. A compound according to claim 1, namely 4-methylaminomethyl 5-äthyl-2,3,4,5-tetrahydrothiopyrano[3,2-b]indol.5-ethyl-2,3,4,5-tetrahydrothiopyrano [3,2-b] indole. 18. Verbindung nach Anspruch 1, nämlich 4-Dimethylaminomethyl-18. Compound according to claim 1, namely 4-dimethylaminomethyl 5~methyl-2,3,4,5-tetrahydrothiopyrano[3,2-b]indol. 255-methyl-2,3,4,5-tetrahydrothiopyrano [3,2-b] indole. 25th 19. Verbindung nach Anspruch 1, nämlich 4-Methylaminomethyl-5-methyl-2,3,4,5-tetrahydrothiopyrano[3,2-b]indol-1-oxid. 19. The compound of claim 1 which is 4-methylaminomethyl-5-methyl-2,3,4,5-tetrahydrothiopyrano [3,2-b] indole-1-oxide. 20. Verbindung nach Anspruch 1, nämlich 4-Methylaminomethyl-30 20. The compound of claim 1 which is 4-methylaminomethyl-30 5-allyl-2,3,4,5-tetrahydrothiopyrano[3,2-b]indol.5-allyl-2,3,4,5-tetrahydrothiopyrano [3,2-b] indole. 21. Verbindung nach Anspruch 1, nämlich 4-N-Methyl-N-(N,N-diäthylaminoäthyl)-aminomethyl-S-methyl^,3,4,5-tetrahydrothiopyrano 13,2-b]indol.21. A compound according to claim 1, namely 4-N-methyl-N- (N, N-diethylaminoethyl) aminomethyl-S-methyl ^, 3,4,5-tetrahydrothiopyrano 13,2-b] indole. L JL J 22. Verfahren zur Herstellung einer Verbindung der allgemeinen Formel I22. Process for the preparation of a compound of the general Formula I. 1010 2020th (D(D 12 3 4
in der R , R , R , R und η die vorstehend angegebe-
12 3 4
in which R, R, R, R and η are the above
ne Bedeutung haben,
* dadurch gekennzeichnet, daß man
have a meaning
* characterized in that one
(a) eine Verbindung der allgemeinen Formel II 15(a) a compound of the general formula II 15 Hu)Hu) R1 ..CHOR 1 ..CHO in der R die vorstehend genannte Bedeutung hat,in which R has the meaning given above, einer Reaktion mit Ammoniak oder einem primären oder sekundären Amin unter reduktiven Bedingungen oder einer anschließenden Reduktion unterwirft, nötigenfalls .a reaction with ammonia or a primary or secondary amine under reductive conditions or subject to a subsequent reduction, if necessary. (b) eine Verbindung der allgemeinen Formel I, in der(b) a compound of the general formula I in which R. ein Wasserstoffatom bedeutet, einer Reaktion zur Einführung eines Substituenten in die 5-Stellung unterwirft,R. represents a hydrogen atom, a reaction to introduce a substituent at the 5-position subject, (c) eine Verbindung der allgemeinen Formel I, in der η den Wert O hat, einer Oxidation mit einer Persäure unterwirft, wobei das entsprechende Oxid oder Dioxid erhalten wird und
(d) eine Verbindung der allgemeinen Formel I zur Modifizierung ihrer Substituenten einer entsprechenden
(c) Subjecting a compound of the general formula I in which η has the value O to an oxidation with a peracid, the corresponding oxide or dioxide being obtained and
(d) a compound of the general formula I for modifying its substituents of a corresponding one
Reaktion unterwirft.Reaction subjects. U . -JU -J Γ - 5 - Γ - 5 - 23. Arzneimittel, enthaltend mindestens eine Verbindung gemäß den Ansprüchen 1 bis 21 und pharmazeutisch verträgliche Träger.23. Medicaments containing at least one compound according to claims 1 to 21 and pharmaceutically acceptable Carrier.
DE1981101451 1980-02-27 1981-02-27 Tetrahydrothiopyrano (3,2-b) indole derivatives, processes for their preparation and pharmaceutical compositions containing these compounds Pending DE35259T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2375180 1980-02-27

Publications (1)

Publication Number Publication Date
DE35259T1 true DE35259T1 (en) 1982-03-18

Family

ID=

Similar Documents

Publication Publication Date Title
DE137145T1 (en) CAMPTOTHECIN DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
DE54951T1 (en) DIBENZO (B, F) (1,4) OXAZEPINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
DE312867T1 (en) GALLEN ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT.
DE116208T1 (en) MITOMYCIN ANALOGS.
DE1104499B (en) Process for the preparation of new amino-substituted triphenylethylene compounds
DE1620449C3 (en) Substituted benzimidazoles and processes for their preparation
EP0086416A3 (en) Corynantheine derivatives, process for their preparation and their use as medicaments
DE35259T1 (en) Tetrahydrothiopyrano (3,2-b) indole derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
DE3510962A1 (en) DIMENSIBLE DIMENSIONS
AT391699B (en) METHOD FOR PRODUCING NEW 4-CHLORO SUBSTITUTED FURO- (3,4-C) -PYRIDINE DERIVATIVES
DE2233568A1 (en) NEW DERIVATIVES OF PHENANTHRIDINE, THEIR PRODUCTION AND MEDICAL COMPOSITIONS THEREOF
DE255149T1 (en) PYRROLIDIN-2-ON DERIVATIVES WITH NOOTROPER ACTIVITY.
DE73155T1 (en) ANTITUARY ACTIVITIES.
DE326326T1 (en) CYSTEIN DERIVATIVES.
DE2757431A1 (en) 5-FLUORURACIL DERIVATIVES AND AGENTS CONTAINING THEM
DE2403786A1 (en) NEW DERIVATIVES OF CUMARINE
EP0013252A1 (en) Cardiac rhythm reduction agent
DE124777T1 (en) DERIVATIVES OF 1,4-DIHYDROPYRIDINE.
DE2657770A1 (en) 8-AMINOCARBONYL AND SULFONYL SUBSTITUTED ERGOLINS, THEIR USE AND MANUFACTURING
DE2738131A1 (en) AMINO KETONES, THE METHOD OF MANUFACTURING THEM AND THE MEDICINAL PRODUCTS CONTAINING THEM
AT338781B (en) PROCESS FOR THE PREPARATION OF NEW 1,3-BENZODIOXOL DERIVATIVES AND THEIR SALTS
DE1445415A1 (en) Process for the preparation of imidazolidinones
AT337180B (en) PROCESS FOR THE PREPARATION OF NEW 1,3-BENZO-DIOXOL DERIVATIVES AND THEIR SALTS
AT330153B (en) PROCESS FOR THE PREPARATION OF NEW 1-CYANOPHENOXY-2-HYDROXY -3- PROPARGYLAMINOPROPANES AND THEIR ACID ADDITION SALTS
DE1643237C3 (en) Nuclear-substituted 1-nitrilophenoxy-3-tert-butylamino-2-propanols, processes for their production and pharmaceutical preparations based on them